BACKGROUND: The aim of this study was to evaluate the influence of oral vitamin E therapy on serum concentrations of several markers of micro-inflammation and cardiovascular disease in chronic hemodialysis (HD) patients. METHODS: 29 HD patients were randomized into two groups: 15 patients were treated orally with 400 mg of vitamin E daily for a period of five weeks, and 14 patients received no antioxidant supplementation. Before and after vitamin E therapy, serum concentrations of vitamin E (high-performance liquid chromatography), pregnancy-associated plasma protein-A (immunochemical--TRACE assay), C-reactive protein (nephelometry), intercellular adhesion molecule-1 (ELISA), and E-selectin (ELISA) were measured. HD patients were compared with 16 healthy controls. RESULTS: Baseline serum concentrations of PAPP-A and CRP were significantly higher in HD patients than in healthy controls (PAPP-A: 26.23+/-11.94 vs. 11.41+/-1.94 mIU/L, p<0.001; CRP: 5.20+/-3.50 vs. 3.40+/-3.80 mg/L, p<0.05). After five weeks of oral vitamin E intake, serum PAPP-A, CRP, ICAM-1, and E-selectin concentrations remained unchanged in both groups of HD patients. CONCLUSION: Chronic micro-inflammation in HD patients is documented by the elevation of CRP and PAPP-A. A daily oral dose of 400 mg of vitamin E does not seem to be able to reduce enhanced oxidative stress and micro-inflammation in chronic HD patients.

Department of Nephrology Institute of Clinical Chemistry and Laboratory Diagnostics General Teaching Hospital and 1st Faculty of Medicine Charles University Prague Czech Republic

000      

00000naa 2200000 a 4500

001      

bmc07522665

003      

CZ-PrNML

005      

20120118225604.0

008      

090506s2006 xxu e eng||

009      

AR

040    __

$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Hodková, Magdaléna. $7 _AN030523

245    10

$a Influence of oral vitamin E therapy on micro-inflammation and cardiovascular disease markers in chronic hemodialysis patients / $c Hodková M., Dusilová-Sulková S., Kalousová M., Soukupová J., Zima T., Miková D., Malbohan I.M., Bartůňková J.

314    __

$a Department of Nephrology, Institute of Clinical Chemistry and Laboratory Diagnostics, General Teaching Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic. magdalena.hodkova@seznam.cz

520    9_

$a BACKGROUND: The aim of this study was to evaluate the influence of oral vitamin E therapy on serum concentrations of several markers of micro-inflammation and cardiovascular disease in chronic hemodialysis (HD) patients. METHODS: 29 HD patients were randomized into two groups: 15 patients were treated orally with 400 mg of vitamin E daily for a period of five weeks, and 14 patients received no antioxidant supplementation. Before and after vitamin E therapy, serum concentrations of vitamin E (high-performance liquid chromatography), pregnancy-associated plasma protein-A (immunochemical--TRACE assay), C-reactive protein (nephelometry), intercellular adhesion molecule-1 (ELISA), and E-selectin (ELISA) were measured. HD patients were compared with 16 healthy controls. RESULTS: Baseline serum concentrations of PAPP-A and CRP were significantly higher in HD patients than in healthy controls (PAPP-A: 26.23+/-11.94 vs. 11.41+/-1.94 mIU/L, p<0.001; CRP: 5.20+/-3.50 vs. 3.40+/-3.80 mg/L, p<0.05). After five weeks of oral vitamin E intake, serum PAPP-A, CRP, ICAM-1, and E-selectin concentrations remained unchanged in both groups of HD patients. CONCLUSION: Chronic micro-inflammation in HD patients is documented by the elevation of CRP and PAPP-A. A daily oral dose of 400 mg of vitamin E does not seem to be able to reduce enhanced oxidative stress and micro-inflammation in chronic HD patients.

650    _2

$a financování organizované $7 D005381

650    _2

$a aplikace orální $7 D000284

650    _2

$a biologické markery $x krev $7 D015415

650    _2

$a C-reaktivní protein $x analýza $7 D002097

650    _2

$a kardiovaskulární nemoci $x etiologie $x krev $7 D002318

650    _2

$a E-selektin $x krev $7 D019040

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a lidé $7 D006801

650    _2

$a zánět $x krev $7 D007249

650    _2

$a mezibuněčná adhezivní molekula-1 $x krev $7 D018799

650    _2

$a chronické selhání ledvin $x komplikace $x terapie $7 D007676

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a lidé středního věku $7 D008875

650    _2

$a těhotenský plazmatický protein A $x analýza $7 D011266

650    _2

$a dialýza ledvin $7 D006435

650    _2

$a vitamin E $x aplikace a dávkování $x krev $7 D014810

655    _2

$a randomizované kontrolované studie $7 D016449

700    1_

$a Sulková, Sylvie, $d 1954- $7 jn20000710614

700    1_

$a Kalousová, Marta, $d 1974- $7 mzk2005318016

700    1_

$a Soukupová, Jiřina

700    1_

$a Zima, Tomáš, $d 1966- $7 jn20000620440

700    1_

$a Miková, Dana, $d 1962- $7 xx0062462

700    1_

$a Matouš-Malbohan, Ivan, $d 1943- $7 xx0104988

700    1_

$a Bartůňková, Jiřina, $d 1958- $7 jn20000400093

773    0_

$w MED00007346 $t Renal failure $g Roč. 28, č. 5 (2006), s. 395-399 $x 0886-022X

910    __

$a ABA008 $b x $y 9

990    __

$a 20090310084605 $b ABA008

991    __

$a 20120118225649 $b ABA008

999    __

$a ok $b bmc $g 650757 $s 503920

BAS    __

$a 3

BMC    __

$a 2006 $b 28 $c 5 $d 395-399 $i 0886-022X $m Renal failure $x MED00007346

LZP    __

$a 2009-B3/ipme